S10 Ep2: Jabbour Reports Top Takeaways From ASH 2023 of Olverembatinib in CML and ALL
Dec 28, 2023
08:07
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Jabbour discusses the activity and the utilization of olverembatinib in chronic myeloid leukemia and expanded upon the role that TKIs can play in the management of malignancies beyond chronic myeloid leukemia and acute lymphoblastic leukemia.
OncLive® On Air